Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 9 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 9745266

    Indoline alkaloid compounds

    The Regents of the University of Colorado · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  2. US 9701713

    Compositions and methods for introduction of macromolecules into cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  3. US 9701792

    Composite compositions and methods of preparing and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  4. US 9700628

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  5. US 9700492

    Dental composites systems and methods of making the same and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  6. US 9695229

    Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  7. US 9687527

    Stable glucagon formulations for the treatment of hypoglycemia

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  8. US 9683025

    Methods and compositions for treating cancer and inflammatory diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  9. US 9675678

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  10. US 9662307

    Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof

    The Regents of the University of Colorado · Granted May 30, 2017 · Expires May 25, 2037

    granted

  11. US 9650447

    Complement receptor 2 (CR2) targeting groups

    The Regents of the University of Colorado, a Body Corporate · Granted May 16, 2017 · Expires May 11, 2037

    granted

  12. US 9639665

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado, a Body Corporate · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  13. US 9631092

    Degradable thiol-ene polymers

    The Regents of the University of Colorado · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  14. US 9629848

    Compounds that modulate autoimmunity and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  15. US 9631188

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  16. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  17. US 9562088

    Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  18. US 9562015

    Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations

    The Regents of the University of Colorado, a body · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  19. US 9539231

    Method for treating triple-negative breast cancer using AMPI-109

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  20. US 9526760

    LEDGF peptides and formulations thereof for treatment of degenerative disorders

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  21. US 9522179

    Compositions and methods for modulating cardiac conditions

    The Regents of the University of Colorado · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  22. US 9518090

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  23. US 9517229

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  24. US 9512481

    Polymorphisms in the PDE3A gene

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.